No Data
No Data
No Data
No Data
No Data
Med-X Withdraws IPO Plan; Elects Not To Pursue Sale Of Securities At This Time - Filing
https://www.sec.gov/Archives/edgar/data/1620704/000147793224002292/medx_rw.htm
BenzingaApr 24 05:39
Med-X Withdraws IPO Filing
Med-X Withdraws IPO Filing
Dow JonesApr 24 04:58
Med-X Secures High-Priority Order to Address Bed Bug Issue Impacting the Republic of Singapore
Med-X Fulfills Bulk Order to Address Urgent Bed Bug Issue Impacting SingaporeAll-Natural Nature-Cide Products Provide a Safe Alternative to Control Pests in Sensitive Areas such as Homes and HotelsLOS
AccesswireDec 14, 2023 21:31
Med-X Announces International Expansion of Nature-Cide Product Distribution With Global Pest Control Leader Ensystex
Med-X Builds Upon Early Successes of U.S. Distribution Agreement with Ensystex, Fortifying Nature-Cide's Global Sales Footprint in 29 Territories Across Asia, Oceana, Southern Africa and the Middle Ea
AccesswireDec 4, 2023 21:31
Med-X Acquires 49% Interest in NAPCO Painting Contractors
Med-X Makes Strategic Minority Investment in a Napa Valley Based Green Scene Painting CompanyManagement Exploring Nature-Cide Insecticidal Paint Additive Alongside NAPCO TeamLOS ANGELES, CA / ACCESSWI
AccesswireOct 4, 2023 20:31
Med-X Expects to Offer 1.15M Shrs in IPO at Price of $4 to $6 Each, Previously Expected to Offer 2.125M Shares With Assumed Price of $4 Each
Med-X Expects to Offer 1.15M Shrs in IPO at Price of $4 to $6 Each, Previously Expected to Offer 2.125M Shares With Assumed Price of $4 Each
Dow JonesOct 4, 2023 05:24
No Data
No Data